Physicochemical Properties
| Molecular Formula | C37H62F3N13O12 |
| Molecular Weight | 937.96 |
| Related CAS # | C3a (70-77);63555-63-5 |
| Appearance | Solid powder |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Human mononuclear leukocytes in culture that are directly interacting with C3a(70–77) exhibit concentration-dependent suppression of the synthesis of LIF elicited by mitogens and the antigen SK-SD[1]. C3a(70–77) increases vascular permeability in human skin, stimulates contraction of guinea pig ileal tissue, and causes histamine release and degranulation of rat mast cells. Ileal smooth muscle is desensitized to C3a(70–77) but not to human C5a, a similar anaphylatoxin. Cross-desensitization suggests that C3a(70–77) interacts with cellular C3a binding sites in a particular way[2]. |
| References |
[1]. Modulation of human lymphocyte function by C3a and C3a(70-77). J Exp Med. 1982 Sep 1;156(3):756-65. [2]. The active site of C3a anaphylatoxin. J Biol Chem. 1980 Nov 25;255(22):10758-63. |
Solubility Data
| Solubility (In Vitro) | H2O :~100 mg/mL (~106.61 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (106.61 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.0661 mL | 5.3307 mL | 10.6614 mL | |
| 5 mM | 0.2132 mL | 1.0661 mL | 2.1323 mL | |
| 10 mM | 0.1066 mL | 0.5331 mL | 1.0661 mL |